pentobarbital will decrease the level or outcome of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use of alternative treatments is strongly recommended when linagliptin should be to be administered that has a CYP3A4 inducerpentobarbital will minimize the level or effect of cannabidiol by impacting hepa